By in vitro-stimulation of CD8+ T lymphocytes with peptide-loaded DCs we identified an autochthonously generated HLA-A*0201-presented, prostein-derived peptide which was able to stimulate tumor-reactive CTLs [100]. The gene discussed is CD8A; the disease is neoplasm.